BRIEF-Abbvie CEO says "big" M&A is something that is not fundamental to their strategy
July 28, 2017 at 10:21 AM EDT
* Abbvie CFO: humira u.s. Sales increased 18 percent compared to the prior year, driven by low double-digit prescription growth plus price.
